Heterocyclic Anticancer Agents
Seiten
2022
De Gruyter (Verlag)
978-3-11-073926-8 (ISBN)
De Gruyter (Verlag)
978-3-11-073926-8 (ISBN)
Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.
lt;p>Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.
| Erscheinungsdatum | 10.05.2022 |
|---|---|
| Zusatzinfo | 50 b/w and 100 col. ill., 50 b/w and 15 col. tbl. |
| Verlagsort | Berlin/Boston |
| Sprache | englisch |
| Maße | 170 x 240 mm |
| Gewicht | 1017 g |
| Themenwelt | Naturwissenschaften ► Chemie ► Technische Chemie |
| Technik | |
| Schlagworte | Anticancer agents • Heterocycles • Krebsbekämpfung • Organic Chemistry • Organische Chemie • Pharmaceutical Chemistry. • Pharmazeutische Chemie |
| ISBN-10 | 3-11-073926-7 / 3110739267 |
| ISBN-13 | 978-3-11-073926-8 / 9783110739268 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Grundlagen, technische Anwendungen, Rohstoffe, Analytik und …
Buch | Softcover (2023)
Springer Vieweg (Verlag)
CHF 55,95
erneuerbare Energien und Speichertechnologien für die Energiewende
Buch | Softcover (2023)
De Gruyter Oldenbourg (Verlag)
CHF 97,90
Daten, Formeln, Normen, vergleichende Betrachtungen
Buch | Softcover (2024)
Europa-Lehrmittel (Verlag)
CHF 54,45
